EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Impact of Radiofrequency Ablation on Uncovered Metal Stent Patency in Malignant Biliary Obstruction from Pancreatic Cancer

Lillian Wang, Shuji Mitsuhashi, Ryan J Law, Daniel M Simadibrata, Ross Dierkhising, Aishwarya Yamparala, Aliana Bofill-Garcia, Andrew C Storm, Eric J. Vargas, John A. Martin, Barham K Abu Dayyeh, Vinay Chandrasekhara

Endoscopy International Open · 2026-10-26

DOI: 10.1055/a-2989-1743 ↗
AbstractBibliografische Angaben

Abstract

Background and study aims: Pancreatic ductal adenocarcinoma (PDAC) with malignant biliary obstruction is frequently unresectable and carries a median survival of less than one year. Uncovered self-expandable metal stents (UCSEMS) are standard for biliary decompression but are limited by tumor ingrowth. Temperature-controlled endobiliary radiofrequency ablation (TC-RFA) has been proposed to prolong stent patency. We evaluated the efficacy and safety of TC-RFA followed by UCSEMS compared with UCSEMS alone for PDAC-related biliary stricture. Patients and methods: In this single-center study, PDAC patients were prospectively treated with TC-RFA plus UCSEMS and compared with a retrospective cohort treated with UCSEMS alone. The primary outcome was time to recurrent biliary obstruction (TRBO) within six months. Secondary outcomes included technical and clinical success, adverse events (AEs), surgical resection, and mortality. Results: Among 176 patients, 129 received UCSEMS alone and 47 received TC-RFA plus UCSEMS. Technical success was higher with UCSEMS alone (100% vs. 95.7%; p = 0.02), while clinical success was similar between groups (94.4% vs. 95.7%; p = 0.72). Six-month cumulative incidence of recurrent biliary obstruction (RBO) was significantly higher with TC-RFA (56.5% vs. 24.0%; p

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →